Comparative Effectiveness of Tofacitinib and Adalimumab in Axial Spondyloarthritis: A Real-World Clinical Context Multicenter Study.

Rudra Prosad Goswami Debanjali Sinha Moumita Chatterjee Danveer Bhadu Shyamashis Das

Published in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2024)

Tofacitinib showed comparable effectiveness with adalimumab in patients with AxSpA at the sixth month, despite lesser response in the initial months, with favorable ICER drug .

Keyphrases

rheumatoid arthritis
disease activity
ulcerative colitis
ankylosing spondylitis
juvenile idiopathic arthritis
randomized controlled trial
systematic review
hidradenitis suppurativa
adverse drug
drug induced